Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
GPR55 Biologics Sequence Review Report 2026: G protein-coupled receptor 55 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR55 Biologics Sequence Review Report 2026: G protein-coupled receptor 55 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR55 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR52 Biologics Sequence Review Report 2026: G protein-coupled receptor 52 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR52 Biologics Sequence Review Report 2026: G protein-coupled receptor 52 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR52 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR35 Biologics Sequence Review Report 2026: G protein-coupled receptor 35 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR35 Biologics Sequence Review Report 2026: G protein-coupled receptor 35 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR35 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR26 Biologics Sequence Review Report 2026: G protein-coupled receptor 26 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR26 Biologics Sequence Review Report 2026: G protein-coupled receptor 26 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR26 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR22 Biologics Sequence Review Report 2026: G protein-coupled receptor 22 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR22 Biologics Sequence Review Report 2026: G protein-coupled receptor 22 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR22 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR20 Biologics Sequence Review Report 2026: G protein-coupled receptor 20 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR20 Biologics Sequence Review Report 2026: G protein-coupled receptor 20 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR20 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR18 Biologics Sequence Review Report 2026: N-arachidonyl glycine receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR18 Biologics Sequence Review Report 2026: N-arachidonyl glycine receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR18 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR176 Biologics Sequence Review Report 2026: G protein-coupled receptor 176 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR176 Biologics Sequence Review Report 2026: G protein-coupled receptor 176 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR176 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR17 Biologics Sequence Review Report 2026: Uracil nucleotide/cysteinyl leukotriene receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR17 Biologics Sequence Review Report 2026: Uracil nucleotide/cysteinyl leukotriene receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR17 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR161 Biologics Sequence Review Report 2026: G protein-coupled receptor 161 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR161 Biologics Sequence Review Report 2026: G protein-coupled receptor 161 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR161 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR157 Biologics Sequence Review Report 2026: G protein-coupled receptor 157 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR157 Biologics Sequence Review Report 2026: G protein-coupled receptor 157 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR157 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR151 Biologics Sequence Review Report 2026: G protein-coupled receptor 151 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR151 Biologics Sequence Review Report 2026: G protein-coupled receptor 151 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR151 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →